Correlation Between Curative Biotechnology and Tempest Therapeutics
Can any of the company-specific risk be diversified away by investing in both Curative Biotechnology and Tempest Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Curative Biotechnology and Tempest Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Curative Biotechnology and Tempest Therapeutics, you can compare the effects of market volatilities on Curative Biotechnology and Tempest Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Curative Biotechnology with a short position of Tempest Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Curative Biotechnology and Tempest Therapeutics.
Diversification Opportunities for Curative Biotechnology and Tempest Therapeutics
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Curative and Tempest is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Curative Biotechnology and Tempest Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tempest Therapeutics and Curative Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Curative Biotechnology are associated (or correlated) with Tempest Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tempest Therapeutics has no effect on the direction of Curative Biotechnology i.e., Curative Biotechnology and Tempest Therapeutics go up and down completely randomly.
Pair Corralation between Curative Biotechnology and Tempest Therapeutics
Given the investment horizon of 90 days Curative Biotechnology is expected to generate 1.75 times more return on investment than Tempest Therapeutics. However, Curative Biotechnology is 1.75 times more volatile than Tempest Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Tempest Therapeutics is currently generating about 0.03 per unit of risk. If you would invest 2.08 in Curative Biotechnology on August 24, 2024 and sell it today you would lose (1.28) from holding Curative Biotechnology or give up 61.54% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 98.07% |
| Values | Daily Returns |
Curative Biotechnology vs. Tempest Therapeutics
Performance |
| Timeline |
| Curative Biotechnology |
| Tempest Therapeutics |
Curative Biotechnology and Tempest Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Curative Biotechnology and Tempest Therapeutics
The main advantage of trading using opposite Curative Biotechnology and Tempest Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Curative Biotechnology position performs unexpectedly, Tempest Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tempest Therapeutics will offset losses from the drop in Tempest Therapeutics' long position.| Curative Biotechnology vs. Biotron Limited | Curative Biotechnology vs. biOasis Technologies | Curative Biotechnology vs. Covalon Technologies | Curative Biotechnology vs. Mosaic Immunoengineering |
| Tempest Therapeutics vs. Lyra Therapeutics | Tempest Therapeutics vs. Hookipa Pharma | Tempest Therapeutics vs. Cingulate Warrants | Tempest Therapeutics vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |